Eagle Pharmaceuticals Inc (EGRX)
0.95
+0.05
(+5.56%)
USD |
OTCM |
Nov 22, 16:00
Eagle Pharmaceuticals Shareholders Equity (Quarterly): 252.04M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 252.04M |
| March 31, 2023 | 242.84M |
| December 31, 2022 | 233.56M |
| September 30, 2022 | 231.78M |
| June 30, 2022 | 237.98M |
| March 31, 2022 | 215.96M |
| December 31, 2021 | 176.45M |
| September 30, 2021 | 185.29M |
| June 30, 2021 | 194.85M |
| March 31, 2021 | 191.08M |
| December 31, 2020 | 186.01M |
| September 30, 2020 | 172.79M |
| June 30, 2020 | 183.96M |
| March 31, 2020 | 181.83M |
| December 31, 2019 | 179.17M |
| September 30, 2019 | 175.76M |
| June 30, 2019 | 172.48M |
| March 31, 2019 | 175.36M |
| December 31, 2018 | 160.76M |
| September 30, 2018 | 194.06M |
| Date | Value |
|---|---|
| June 30, 2018 | 185.73M |
| March 31, 2018 | 178.18M |
| December 31, 2017 | 179.14M |
| September 30, 2017 | 171.08M |
| June 30, 2017 | 165.36M |
| March 31, 2017 | 166.83M |
| December 31, 2016 | 151.23M |
| September 30, 2016 | 105.52M |
| June 30, 2016 | 107.83M |
| March 31, 2016 | 92.32M |
| December 31, 2015 | 90.34M |
| September 30, 2015 | 87.63M |
| June 30, 2015 | 96.45M |
| March 31, 2015 | 102.88M |
| December 31, 2014 | 27.91M |
| September 30, 2014 | 33.10M |
| June 30, 2014 | 41.91M |
| March 31, 2014 | 44.69M |
| December 31, 2013 | 0.7747M |
| September 30, 2013 | 2.054M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
172.79M
Minimum
Sep 2020
252.04M
Maximum
Jun 2023
204.37M
Average
191.08M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 14.24B |
| Verrica Pharmaceuticals Inc | -34.05M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 404.82M |
| Total Liabilities (Quarterly) | 152.78M |